CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
113 hedge funds and large institutions have $75.4M invested in Clovis Oncology, Inc. in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 52 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
62% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 52
72% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 47
Holders
113
Holding in Top 10
1
Calls
$12.2M
Puts
$9.84M
Top Buyers
| 1 | +$3.24M | |
| 2 | +$2.87M | |
| 3 | +$1.49M | |
| 4 |
E
Ergoteles
New York
|
+$1.27M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$328K |
Top Sellers
| 1 | -$32.4M | |
| 2 | -$9.47M | |
| 3 | -$3.63M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.03M |
| 5 |
HF
HRT Financial
New York
|
-$1.73M |